Ventricular Tachycardia in Patients with Coronary Artery Disease

Cardiac Electrophysiology: Fourth Edition

Volumn , Issue , 2004, Pages 569-574

  Callans, David J ^a   Josephson, Mark E ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Harvard Thorndike Electrophysiology Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904139235     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-7216-0323-8/50064-6     Document Type: Chapter

References (27)

1. Josephson ME Clinical Cardiac Electrophysiology: Techniques and Interpretations 2002, Lippincott Williams & Wilkins, Philadelphia. 3rd ed.
2. de Bakker JM, Janse MJ Pathophysiological correlates of ventricular tachycardia in hearts with a healed infarct. Cardiac Electrophysiology: From Cell to Bedside 2000, 415-421. WB Saunders, Philadelphia. 3rd ed. D.P. Zipes, J. Jalife (Eds.).
3. Zheng Z-J, Croft JB, Giles WH, Mensah GA Sudden cardiac death in the United States, 1989 to 1998. Circulation 1998, 104:2158-2163.
4. Peters NS, Coromilas J, Severs NJ, Wit AL Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 1997, 95:988-996.
5. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000, 342:1937-1945.
6. Gomes JA, Mehta D, Ip J, et al. Predictors of long-term survival in patients with malignant ventricular arrhythmias. Am J Cardiol 1997, 79:1054-1060.
7. Wyse DG, Friedman PL, Brodsky MA, et al. Life-threatening ventricular arrhythmias due to transient or correctable causes: High risk for death in follow-up. J Am Coll Cardiol 2001, 38:1718-1724.
8. Callans DJ, Josephson ME Ventricular tachycardia in patients with coronary artery disease. Cardiac Electrophysiology: From Cell to Bedside 2000, 530-536. WB Saunders, Philadelphia. 3rd ed. D.P. Zipes, J. Jalife (Eds.).
9. Peters NS, Cabo C, Wit AL Arrhythmogenic mechanisms: Automaticity, triggered activity, and reentry. Cardiac Electrophysiology: From Cell to Bedside 2000, 345-356. WB Saunders, Philadelphia. 3rd ed. D.P. Zipes, J. Jalife (Eds.).
10. Callans DJ, Hook BG, Mitra RL, Josephson ME Characterization of return cycle responses predictive of successful pacing-mediated termination of ventricular tachycardia. J Am Coll Cardiol 1995, 25:47-53.
11. El-Shalakany A, Hadjis T, Papageorgiou P, et al. Entrainment mapping criteria for the prediction of termination of ventricular tachycardia by single radiofrequency lesion in patients with coronary artery disease. Circulation 1999, 99:2283-2289.
12. Hanna MS, Coromilas J, Josephson ME, et al. Mechanisms of resetting reentrant circuits in canine ventricular tachycardia. Circulation 2001, 103:1148-1156.
13. Peters NS, Coromilas J, Hanna MS, et al. Characteristics of the temporal and spatial excitable gap in anisotropic reentrant circuits causing sustained ventricular tachycardia. Circ Res 1998, 82:279-293.
14. Bogun F, Bahu M, Knight BP, et al. Response to pacing at sites of isolated diastolic potentials during ventricular tachycardia in patients with previous myocardial infarction. J Am Coll Cardiol 1997, 30:505-513.
15. Callans DJ, Zardini M, Gottlieb CD, Josephson ME The variable contribution of functional and anatomic barriers in human ventricular tachycardia: An analysis with resetting from two sites. J Am Coll Cardiol 1996, 27:1106-1111.
16. Ho RT, Callans DJ Malignant ventricular arrhythmias. Cardiovascular Therapeutics 2002, 477-502. WB Saunders, Philadelphia. 2nd ed. E.M. Antman (Ed.).
17. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: An international consensus on science. Part 6: Advanced Cardiovascular Life Support; Section 5: Pharmacology I: Agents for arrhythmias. Circulation 2000, 102:I112-I128.
18. Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Study Group. J Am Coll Cardiol 1996, 27:67-75.
19. Naccarelli GV, Wolbrette DL, Dell'Orfano JT, et al. A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: From CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable Defibrillators. J Cardiovasc Electrophysiol 1998, 9:864-891.
20. Josephson ME, Callans DJ, Buxton AE The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death. Ann Intern Med 2000, 133:901-910.
21. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997, 337:1576-1583.
22. Larsen G, Hallstrom A, McAnulty J, et al. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy. Circulation 2002, 105:2049-2057.
23. Domanski MJ, Sakseena S, Epstein AE, et al. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol 1999, 34:1090-1095.
24. Hallstrom AP, McAnulty JH, Wilkoff BL, et al. Patients at lower risk of arrhythmia recurrence: A subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. J Am Coll Cardiol 2001, 37:1093-1099.
25. Caruso AC, Marcus FI, Hahn EA, et al. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring. Circulation 1997, 96:1888-1892.
26. Pinski SL, Yao Q, Epstein AE, et al. Determinants of outcome in patients with sustained ventricular tachyarrhythmias: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Study Registry. Am Heart J 2000, 139:804-813.
27. Rothman SA, Hsia HH, Cossu SF, et al. Radiofrequency catheter ablation of postinfarction ventricular tachycardia: Long-term success and the significance of inducible nonclinical arrhythmias. Circulation 1997, 96:3499-3508.